Analysts expect Krystal Biotech, Inc. to report revenue of 139.13 M for Q4 26, against a range of 125.43 M to 152.83 M. The most recent reported quarter, Q3 26, came in at 127.34 M, a 8.0% beat against the 117.94 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 91.14 M | 88.18 M | 96.04 M | 97.80 M | 107.11 M | 116.36 M | 119.22 M | 127.34 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 103.33 M | 97.42 M | 105.22 M | 92.96 M | 117.61 M | 128.88 M | 122.72 M | 127.14 M | 152.83 M | 139.39 M | 148.24 M | 180.46 M | 171.49 M | 218.04 M | 205.33 M | 247.47 M | |||||||||
| Low Estimate | 85.42 M | 82.82 M | 90.40 M | 83.77 M | 97.64 M | 108.86 M | 114.27 M | 108.74 M | 125.43 M | 122.26 M | 136.28 M | 156.29 M | 142.75 M | 186.29 M | 184.28 M | 214.10 M | |||||||||
| Consensus Estimate | 94.38 M | 90.12 M | 97.81 M | 88.37 M | 107.62 M | 118.87 M | 118.50 M | 117.94 M | 139.13 M | 130.83 M | 142.26 M | 168.37 M | 157.12 M | 202.16 M | 194.81 M | 230.78 M |
Analysts expect Krystal Biotech, Inc. to report earnings per share of 1.95 for Q4 26, against a range of 1.78 to 2.12. The most recent reported quarter, Q3 26, came in at 2.05, a 11.4% beat against the 1.84 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.52 | 1.20 | 1.29 | 2.66 | 1.70 | 1.83 | 1.79 | 2.05 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.17 | 1.44 | 1.32 | 1.11 | 1.61 | 1.67 | 1.71 | 1.90 | 2.12 | 2.21 | 2.38 | 2.42 | 2.14 | 3.07 | 3.08 | 3.39 | |||||||||
| Low Estimate | 1.07 | 1.22 | 1.18 | 0.97 | 1.41 | 1.51 | 1.53 | 1.78 | 1.78 | 1.83 | 2.12 | 2.10 | 1.96 | 2.69 | 2.62 | 3.15 | |||||||||
| Consensus Estimate | 1.12 | 1.33 | 1.25 | 1.04 | 1.51 | 1.59 | 1.62 | 1.84 | 1.95 | 2.02 | 2.25 | 2.26 | 2.05 | 2.88 | 2.85 | 3.27 |
Pull Wall Street consensus for Krystal Biotech, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KRYS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KRYS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KRYS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();